SS
ADMA icon

SBI Securities’s ADMA Biologics ADMA Stock Holding History

SBI Securities’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Sell
7,664
-508
-6% -$4.63K ﹤0.01% 1073
2026
Q1 		$73.6K Buy
8,172
+61
+0.8% +$963 ﹤0.01% 954
2025
Q4 		$148K Sell
8,111
-242
-3% -$4.08K ﹤0.01% 719
2025
Q3 		$122K Buy
8,353
+99
+1% +$1.7K ﹤0.01% 788
2025
Q2 		$150K Sell
8,254
-134
-2% -$2.73K ﹤0.01% 672
2025
Q1 		$166K Buy
8,388
+164
+2% +$2.84K 0.01% 579
2024
Q4 		$141K Buy
+8,224
New +$155K ﹤0.01% 644

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SBI Securities's ADMA Position: Q2 2026 in Review

SBI Securities reduced its ADMA Biologics (ADMA) stake by 6.2% in Q2 2026, selling an estimated $4.63K and leaving 7,664 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

SBI Securities first reported a position in ADMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $166K in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • SBI Securities held 7,664 shares of ADMA Biologics worth $64.1K as of Q2 2026.
  • SBI Securities sold 508 ADMA Biologics shares in Q2 2026, an estimated $4.63K.
  • ADMA Biologics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1073 holding.
  • SBI Securities first reported a position in ADMA Biologics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's ADMA Biologics position peaked at $166K in Q1 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.